DR. NEZIH CEREB, M.D.
Medical Practice at Executive Blvd, Crotonville, NY
License number
New York 206119
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
300 Executive Blvd, Crotonville, NY 10562
Phone
(914) 762-0300
(914) 762-4441 (Fax)
(914) 762-4441 (Fax)
Organization information
See more information about NEZIH CEREB at bizstanding.comNezih Cereb MD
300 Executive Blvd, Ossining, NY 10562
Industry:
Pediatric Oncologist
Phone:
(914) 762-0300 (Phone)
Nezih Cereb
Professional information
Dr. Nezih Cereb, Ossining NY - MD (Doctor of Medicine)
Specialties:
Pediatric Hematology & Oncology
Address:
HISTOGENETICS
300 Executive Blvd, Ossining 10562
(914) 762-0300 (Phone), (914) 762-4441 (Fax)
300 Executive Blvd, Ossining 10562
(914) 762-0300 (Phone), (914) 762-4441 (Fax)
Certifications:
Pediatric Oncology & Pediatric Hematology, 1994, Pediatrics, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Hacettepe University / Medical Faculty
SUNY Hlth Sci Ctr Brooklyn
Cornell Univ Sch Of Med
Mem Sloan Kettering Cancer Ctr
Hacettepe University / Medical Faculty
SUNY Hlth Sci Ctr Brooklyn
Cornell Univ Sch Of Med
Mem Sloan Kettering Cancer Ctr
Nezih Cereb, Ossining NY
Specialties:
Pediatric Hematologist / Oncologist
Address:
300 Executive Blvd, Ossining, NY 10562
System And Method For Accessing, Tracking, And Editing Sequence Analysis And Software To Accomplish The Same
US Patent:
2007011, May 17, 2007
Filed:
Oct 16, 2006
Appl. No.:
11/582008
Inventors:
Nezih Cereb - Ossining NY, US
Soo Lee - Ossining NY, US
Soo Lee - Ossining NY, US
International Classification:
C12Q 1/68, G06F 19/00
US Classification:
435006000, 702020000
Abstract:
The present invention relates to a system and method for accessing, tracking and editing sequence analysis and software to accomplish the same. The present invention includes embodiments that permit a party, for example a customer, to track the status of the samples (e.g., tissue, blood, or DNA) that the party sends for sequence based typing (“SBT”) analysis. The party can also participate in the analysis by accessing the sequencing data for the submitted samples. A party is able to remotely access tools for sequence based typing (e.g., Histomatcher), and using such tools, the party can review and edit the data. The party can also generate reports via the accessed tools.